Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Device Firms Cheer ICD-10 Debut, While Providers Brace For Chaos

This article was originally published in The Gray Sheet

Executive Summary

The ICD-10 health care coding set has finally launched after much debate and delay. Medical device manufacturers cheer the transition as a means to better capture new technology in the insurance system, but health care providers are bracing for technical headaches and the risk of claims not being paid.

You may also be interested in...



Reimbursement Briefs: AMA Wants ICD-10 Halt; News From CMS, AHRQ And OIG

AMA asks CMS to reconsider ICD-10 implementation. CMS explores specialist payment models. AHRQ quality measures clearinghouse endorses new Medicare hip and knee replacement measures tied to readmissions and complications. More reimbursement news.

Costs Are Central To Arguments For And Against Accelerated ICD-10 Adoption

Device firms and others who support accelerated adoption of a greatly expanded health care billing code system, and payers who warn against moving too fast, each are invoking hot-button economic and health reform issues to make their case

US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising

US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT034260

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel